chr19-36101667-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001083961.2(WDR62):​c.2975C>T​(p.Ser992Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,550,406 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S992S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0088 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 16 hom. )

Consequence

WDR62
NM_001083961.2 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0800

Publications

7 publications found
Variant links:
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
  • microcephaly 2, primary, autosomal recessive, with or without cortical malformations
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031680763).
BP6
Variant 19-36101667-C-T is Benign according to our data. Variant chr19-36101667-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 160276.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00876 (1334/152284) while in subpopulation AFR AF = 0.0297 (1236/41558). AF 95% confidence interval is 0.0284. There are 17 homozygotes in GnomAd4. There are 626 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR62NM_001083961.2 linkc.2975C>T p.Ser992Leu missense_variant Exon 25 of 32 ENST00000401500.7 NP_001077430.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR62ENST00000401500.7 linkc.2975C>T p.Ser992Leu missense_variant Exon 25 of 32 1 NM_001083961.2 ENSP00000384792.1

Frequencies

GnomAD3 genomes
AF:
0.00877
AC:
1334
AN:
152168
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0298
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00233
AC:
359
AN:
154156
AF XY:
0.00169
show subpopulations
Gnomad AFR exome
AF:
0.0309
Gnomad AMR exome
AF:
0.00146
Gnomad ASJ exome
AF:
0.000472
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000652
Gnomad NFE exome
AF:
0.000764
Gnomad OTH exome
AF:
0.00319
GnomAD4 exome
AF:
0.00118
AC:
1652
AN:
1398122
Hom.:
16
Cov.:
32
AF XY:
0.00105
AC XY:
722
AN XY:
689614
show subpopulations
African (AFR)
AF:
0.0311
AC:
982
AN:
31572
American (AMR)
AF:
0.00232
AC:
83
AN:
35702
Ashkenazi Jewish (ASJ)
AF:
0.000397
AC:
10
AN:
25174
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79218
European-Finnish (FIN)
AF:
0.0000205
AC:
1
AN:
48664
Middle Eastern (MID)
AF:
0.00373
AC:
21
AN:
5630
European-Non Finnish (NFE)
AF:
0.000382
AC:
412
AN:
1078452
Other (OTH)
AF:
0.00245
AC:
142
AN:
57976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
101
202
303
404
505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00876
AC:
1334
AN:
152284
Hom.:
17
Cov.:
33
AF XY:
0.00841
AC XY:
626
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0297
AC:
1236
AN:
41558
American (AMR)
AF:
0.00373
AC:
57
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68032
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00308
Hom.:
11
Bravo
AF:
0.0105
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0239
AC:
93
ESP6500EA
AF:
0.000682
AC:
5
ExAC
AF:
0.00198
AC:
108
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 03, 2015
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 29, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Benign:3
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:3
Mar 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

WDR62-related disorder Benign:1
Jul 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
12
DANN
Uncertain
1.0
DEOGEN2
Benign
0.10
.;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.0032
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
0.080
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.044
Sift
Uncertain
0.0040
D;D
Sift4G
Benign
0.074
T;T
Polyphen
0.0090
B;B
Vest4
0.099
MVP
0.43
MPC
0.21
ClinPred
0.0083
T
GERP RS
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.099
gMVP
0.085
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74518295; hg19: chr19-36592569; API